Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD
出版年份 2016 全文链接
标题
Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD
作者
关键词
-
出版物
Frontiers in Aging Neuroscience
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2016-03-11
DOI
10.3389/fnagi.2016.00051
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease
- (2015) Xiaojuan Sun et al. Frontiers in Pharmacology
- Early-Onset Familial Alzheimer's Disease (EOFAD)
- (2014) Liyong Wu et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Alzheimer Presenilin-1 Mutations Dramatically Reduce Trimming of Long Amyloid β-Peptides (Aβ) by γ-Secretase to Increase 42-to-40-Residue Aβ
- (2014) Marty A. Fernandez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evidence of a Novel Mechanism for Partial γ-Secretase Inhibition Induced Paradoxical Increase in Secreted Amyloid β Protein
- (2014) Eliza Barnwell et al. PLoS One
- Changed membrane integration and catalytic site conformation are two mechanisms behind the increased Aβ42/Aβ40 ratio by presenilin 1 familial Alzheimer-linked mutations
- (2014) Johanna Wanngren et al. FEBS Open Bio
- Characterization of Intermediate Steps in Amyloid Beta (Aβ) Production under Near-native Conditions
- (2013) Fredrik Olsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- γ-Secretase Modulators and Presenilin 1 Mutants Act Differently on Presenilin/γ-Secretase Function to Cleave Aβ42 and Aβ43
- (2013) Masayasu Okochi et al. Cell Reports
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- A novel PSEN1 H163P mutation in a patient with early-onset Alzheimer's disease: Clinical, neuroimaging, and neuropathological findings
- (2012) Jungeun Kim et al. NEUROSCIENCE LETTERS
- Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified γ-Secretase Complexes
- (2012) Matthias Cacquevel et al. PLoS One
- Attenuated Aβ42Responses to Low Potency γ-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-generation Compounds
- (2011) Benedikt Kretner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease
- (2010) Gen He et al. NATURE
- A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer’s disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF
- (2009) I. Uttner et al. EUROPEAN JOURNAL OF NEUROLOGY
- -Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of -Carboxyl Terminal Fragment
- (2009) M. Takami et al. JOURNAL OF NEUROSCIENCE
- An Overview of APP Processing Enzymes and Products
- (2009) Vivian W. Chow et al. NEUROMOLECULAR MEDICINE
- Independent Generation of Aβ42 and Aβ38 Peptide Species by γ-Secretase
- (2008) Eva Czirr et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid Precursor Protein Trafficking, Processing, and Function
- (2008) Gopal Thinakaran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ
- (2008) Paul A. Adlard et al. NEURON
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started